Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04724668 · ClinicalTrials.gov registry record · NA
The Role of the Circadian System in Binge Eating Disorder
A NA study of Binge-Eating Disorder and Circadian Rhythm Disorders, sponsored by University of Cincinnati.
- Completed
- Registry status
- NA
- Development phase
- 43
- Enrollment target
- 1
- Study location
NCT04724668 is a NA study of Binge-Eating Disorder and Circadian Rhythm Disorders that has completed, run by University of Cincinnati. The registered enrollment target is 43 participants, below the 1,142-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04724668, a NA study of Binge-Eating Disorder and Circadian Rhythm Disorders, has completed, sponsored by University of Cincinnati.
- COMPLETED
- Registry status
- NA
- Development phase
- 43 participants
- Enrollment target
- 1
- Study location
Study Summary
Binge eating disorder (BED) shows prominent circadian features that suggest a delay in circadian phase, and preliminary evidence shows binge eating may be responsive to chronobiological interventions, implicating a circadian system dysfunction in its pathophysiology. What remains lacking, however, is comprehensive knowledge of the characteristics of circadian system dysfunction in BED, and whether this dysfunction represents a therapeutic target in BED. There is therefore a critical need to characterize circadian system dysfunction in BED, and evaluate it as a potential therapeutic target. Without such information, the understanding on the role of the circadian system in BED and its potential as a new therapeutic target will remain limited.
Conditions Studied
Interventions
- DIETARY_SUPPLEMENT Melatonin (3hrs before DLMO)
- DIETARY_SUPPLEMENT Placebo (3hrs before DLMO)
- DEVICE Morning light version 1
- DEVICE Morning light version 2
Study Locations (1)
Ohio
- Lindner Center of HOPE / University of Cincinnati - Mason
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 43 participants |
| Start Date | 2021-01-15 |
| Est. Completion | 2025-05-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04724668
The ClinicalTrials.gov registry entry for NCT04724668 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 43 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,142-participant average among 37 other Binge-Eating Disorder trials with a reported enrollment target (96% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Binge-Eating Disorder appearing as the primary indexed condition, and to 4 interventions - of which Melatonin (3hrs before DLMO) is the first listed.
NCT04724668 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT04724668 about?
NCT04724668 is a clinical study titled "The Role of the Circadian System in Binge Eating Disorder". Binge eating disorder (BED) shows prominent circadian features that suggest a delay in circadian phase, and preliminary evidence shows binge eating may be responsive to chronobiological interventions, implicating a circadian system dysfunction in its pathophysiology. What remains lacking, however, i...
What is the current status of trial NCT04724668?
This trial is currently completed. It is a NA study. The enrollment target is 43 participants. The study started on 2021-01-15. Estimated completion is 2025-05-30.
What conditions does trial NCT04724668 study?
This clinical trial studies the following conditions: Binge-Eating Disorder, Circadian Rhythm Disorders.
What interventions are being tested in trial NCT04724668?
The interventions under investigation include: Melatonin (3hrs before DLMO) (DIETARY_SUPPLEMENT), Placebo (3hrs before DLMO) (DIETARY_SUPPLEMENT), Morning light version 1 (DEVICE), Morning light version 2 (DEVICE).
Who is sponsoring clinical trial NCT04724668?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04724668 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Binge-Eating Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Use of Circadian Reset Technology to Alter REM Sleep and Appetitive Control in Patients With Binge Eating Disorder
RECRUITING · NA
-
Developing an Artificial Intelligence (AI) Chatbot for Adolescents and Young Adults With Eating Disorders
RECRUITING · NA
-
Treating Binge Eating and Obesity Digitally in Black Women
RECRUITING · NA
-
Preventing Type 2 Diabetes in Black Emergent Adult
RECRUITING · NA
-
Study Comparing Acceptance and Commitment Therapy to Supportive Diabetes Counseling and a Waitlist Control for Eating Disorders in Type 1 Diabetes
RECRUITING · NA
-
Building an Equitable and Accessible System of Eating Disorder Care for VA, DoD, and Underrepresented Americans
RECRUITING · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.